Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?
Benoit Souchet
Mickael Audrain
Baptiste Billoir
Laurent Lecanu
Satoru Tada
Jér?me Braudeau
摘要：Alzheimer's disease (AD) is the most frequent cause of dementia in the western world. In clinical terms, AD is characterized by progres-sive cognitive decline that usually begins with memory impairment.
机标关键词：
论文发表日期：2018-01-01
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 224-225 )